Smart Benefits: Calmar Cancels Out Pain
Monday, December 02, 2013
Now, there's a new approach from Calmar Pain Relief, LLC in West Warwick, Rhode Island, that has an 80 percent success rate with patients. And people from all over the world are traveling here in droves to try it.
The Message? No Pain
Calmar is the only medical treatment center in the United States that treats severe, chronic, neuropathic and oncologic pain patients exclusively with the MC-5A, a new computerized medical device.
The device relies on Scrambler Technology (“ST”) that uses surface electrodes on the skin (similar to an EKG) to transmit synthetic non-pain information through nerve receptors in the area of the patient's pain. The perception of pain is cancelled when the no-pain message replaces that of pain, and the patient experiences a quick and significant reduction of pain.
The treatment involves a series of up to ten treatments over a two-week period. Relief can last several months to a year, and in some cases, permanently. The therapy can also be repeated, if needed.
The MC-5A technology was developed from the research of Professor Giuseppe Marineo, founder and manager of Delta Research and Development, which is affiliated with Tor Vergata University of Rome, Italy. On February 19, 2013, the United States Patent and Trademark Office issued an International Patent for Scrambler Therapy. Scrambler Therapy is also patented in Italy.
Calmar is managed by Dr. Stephen D’Amato, who studied in Italy under Professor Giuseppe Marineo and is the most experienced doctor in the United States using this technology. Besides serving as Medical Director at Calmar, he trains physicians from nationally reknown facilities like the MAYO Clinic in Minnesota and the University of Miami as well as those affiliated with Harvard Medical School.
Hospitals from all over the world who know of Dr. D’Amato and send their worst-case patients to him for help.
Calmar Candidates...and Coverage
Calmar’s pain therapy is available to patients who suffer from complex regional pain syndrome, failed back surgery syndrome, neuropathy of the legs and feet, chemotherapy induced peripheral neuropathy, sciatic and lumber pain, fibromyalgia, and several type of other medical conditions
Insurance carriers are slowly starting to embrace Calmar’s approach, with UnitedHealthcare the first carrier locally to pay for this treatment within their plans.
Following the success in Rhode Island, Calmar has plans to expand into other markets with centers planned soon for Massachusetts and Florida.
- Smart Benefits: 3 Ways Obamacare Hurts Employees
- Smart Benefits: Healthcare Reform Delays Hit Consumers Hard
- Smart Benefits: 5 Health Benefit Cost-Cutting Trends To Watch In 2014
- Smart Benefits: How 3 New RI Laws Will Affect Employers
- Smart Benefits: A Bad Week Brings Reactionary Changes to Obamacare
- Smart Benefits: Be Prepared For Fall Open Enrollment Changes
- Smart Benefits: Employers Who Ignore Obamacare Will Pay
- Smart Benefits: Flexible Spending Accounts Get More Flexible
- Smart Benefits: Gay Marriage Ruling + Employer Compliance
- Smart Benefits: Health Insurers Go Retail